- Lorcaserin,
marketed under the
brand name
Belviq, was a weight-loss drug
developed by
Arena Pharmaceuticals. It
reduces appetite by
activating serotonin...
-
therapeutic areas of interest. The
company has one drug on the market,
Belviq (lorcaserin), a weight-loss medication. The U.S. Food and Drug Administration...
-
February 2020). "FDA
requests the
withdrawal of the weight-loss drug
Belviq,
Belviq XR (lorcaserin) from the market". FDA.
Retrieved 17
February 2020. Central...
- ATC/DDD
Index "FDA
requests the
withdrawal of the weight-loss drug
Belviq,
Belviq XR (lorcaserin) from the market".
Center for Drug
Evaluation and Researcher...
-
receptors in a
region of the
brain called the hypothalamus.
Lorcaserin (
Belviq) was FDA
approved for
weight loss but was
withdrawn from the
market because...
- 347: f5140. doi:10.1136/bmj.f5140. PMID 23970394. S2CID 46738622. "
Belviq,
Belviq XR (lorcaserin) by Eisai: Drug
Safety Communication – FDA
Requests Withdrawal...
- also
reduce cravings.
Observation of the
market performance of
Qsymia and
Belviq suggest overall low
demand for
pharmaceutical obesity therapies, calling...
- Banzel/Inovelon (rufinamide) -
Seizures related to Lennox-Gastaut
Syndrome Belviq (lorcaserin) -
Obesity Dayvigo (lemborexant) -
Insomnia Fragmin (dalteparin)...
- Morehu-Barlow IBM
Australia October 10, 2024 14 The
Magic Pill Fen-Phen
Belviq October 31, 2024 15 The
Descent Titan submersible implosion Steve Fossett...
- Bellergal-S
beloranib (INN)
belotecan (USAN)
beloxamide (INN)
beloxepin (INN)
Belviq (Arena Pharmaceuticals)
bemarinone (INN)
bemegride (INN)
bemesetron (INN)...
